OMNIOMIX CUSTOM NEWS ALERT<br>
-----------------------------------<br>
 <br>
Your Selected KeyWord *TYSABRI* is mentioned in the following NEWS item from Motley Fool.<br>
 <br>
Amgen's Drug-Approval Dilemma<br>
<br>
The full article can be found at:<br>
<a href="http://www.omniomix.com/inthenews.php?id=39584">http://www.omniomix.com/inthenews.php?id=39584</a><br>
<br>
<br>
For Biotech News Updated Throughout the Day Visit http://www.omniomix.com<br>
<br>
<br>
HOW TO CHANGE YOUR SUBSCRIPTION <br>
--------------------------------<br>
<br>
 You received this message because you signed up to receive custom press release alerts from Omniomix. Your Current Selected Custom KeyWord Alerts are for: TYSABRI,stem cells,pharmacogenomics.<br>
<br>
To cancel delivery, change delivery options or change your e-mail address, see http://www.omniomix.com/email_alerts.php